VERTEX PHARMACEUTICALS INC / MA financial data

Symbol
VRTX on Nasdaq
Location
Boston, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 254% % -18%
Quick Ratio 36% % 49%
Debt-to-equity 40% % 18%
Return On Assets 16% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 253,718,831 shares -1.5%
Common Stock, Shares, Outstanding 253,951,475 shares -1.5%
Entity Public Float $121,800,000,000 USD 34%
Common Stock, Value, Issued $2,500,000 USD -3.8%
Weighted Average Number of Shares Outstanding, Basic 255,600,000 shares -0.93%
Weighted Average Number of Shares Outstanding, Diluted 257,600,000 shares -1.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $11,723,300,000 USD 10%
Costs and Expenses $7,729,900,000 USD -29%
Operating Income (Loss) $3,993,400,000 USD 6.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $4,448,700,000 USD 1614%
Income Tax Expense (Benefit) $773,600,000 USD 4.6%
Net Income (Loss) Attributable to Parent $3,675,100,000 USD 3.6%
Earnings Per Share, Basic 14 USD/shares 4.7%
Earnings Per Share, Diluted 14 USD/shares 4.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,939,600,000 USD -5.7%
Marketable Securities, Current $1,347,400,000 USD 4.8%
Accounts Receivable, after Allowance for Credit Loss, Current $1,946,400,000 USD 11%
Inventory, Net $1,626,800,000 USD 51%
Other Assets, Current $76,400,000 USD -9.4%
Assets, Current $10,569,600,000 USD 7.8%
Deferred Income Tax Assets, Net $2,937,200,000 USD 27%
Operating Lease, Right-of-Use Asset $1,591,800,000 USD 14%
Intangible Assets, Net (Excluding Goodwill) $429,800,000 USD -48%
Goodwill $1,088,000,000 USD 0%
Other Assets, Noncurrent $1,098,000,000 USD 11%
Assets $24,862,300,000 USD 12%
Accounts Payable, Current $420,300,000 USD 6.2%
Employee-related Liabilities, Current $352,100,000 USD 19%
Accrued Liabilities, Current $3,613,500,000 USD 12%
Liabilities, Current $4,475,300,000 USD 13%
Operating Lease, Liability, Noncurrent $1,834,800,000 USD 15%
Other Liabilities, Noncurrent $1,233,400,000 USD 32%
Liabilities $7,543,500,000 USD 14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $64,500,000 USD -324%
Retained Earnings (Accumulated Deficit) $12,368,900,000 USD 42%
Stockholders' Equity Attributable to Parent $17,318,800,000 USD 11%
Liabilities and Equity $24,862,300,000 USD 12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $818,900,000 USD -37%
Net Cash Provided by (Used in) Financing Activities $680,400,000 USD -90%
Net Cash Provided by (Used in) Investing Activities $55,800,000 USD 97%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 253,951,475 shares -1.5%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $113,200,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,947,800,000 USD -5.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,700,000 USD -73%
Deferred Tax Assets, Valuation Allowance $272,900,000 USD 2.4%
Deferred Tax Assets, Gross $3,161,400,000 USD 30%
Operating Lease, Liability $1,631,500,000 USD 327%
Payments to Acquire Property, Plant, and Equipment $40,700,000 USD -40%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $3,581,800,000 USD 6.4%
Lessee, Operating Lease, Liability, to be Paid $2,739,200,000 USD 528%
Operating Lease, Liability, Current $87,100,000 USD 163%
Lessee, Operating Lease, Liability, to be Paid, Year Two $158,700,000 USD 283%
Lessee, Operating Lease, Liability, to be Paid, Year One $167,300,000 USD 297%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 83%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $908,500,000 USD 1570%
Lessee, Operating Lease, Liability, to be Paid, Year Three $157,900,000 USD 291%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Unrecognized Tax Benefits $706,200,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Four $154,700,000 USD 324%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $200,600,000 USD 1.5%
Deferred Tax Assets, Net of Valuation Allowance $2,888,500,000 USD 33%
Share-based Payment Arrangement, Expense $696,100,000 USD -5.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%